Costs · adults requiring an artificial airway with or without mechanical ventilator support
1 finding from 1 review
Adverse events · adults requiring an artificial airway with or without mechanical ventilator support
1 finding from 1 review
Proportion able to communicate or phonate · adults requiring an artificial airway with or without mechanical ventilator support
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · adults requiring an artificial airway with or without mechanical ventilator support
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Emotional and psychological distress · adults requiring an artificial airway with or without mechanical ventilator support
1 finding from 1 review
Intervention not reported
Total daily moderate‐to‐vigorous physical activity (MVPA) · health problem or population
1 finding from 1 review
Intervention not reported
Proportion of care session spent in MVPA (% session spent in MVPA) · health problem or population
1 finding from 1 review
Intervention not reported
Cardiovascular fitness (3‐minute endurance test) · health problem or population
1 finding from 1 review
Intervention not reported
Cost‐effectiveness · health problem or population
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
Intervention not reported
Adverse outcomes ‐ not reported · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life ‐ not reported · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adherence to pharmacotherapy: number of people completing treatment · COPD
Single component intervention showed no clear difference in adherence to pharmacotherapy: number of people completing treatment compared with control (low certainty).
1 finding from 1 review
Adverse events: number of people experiencing adverse events (all cause or COPD‐related), serious adverse events, mortality · COPD
Multi‐component intervention showed no clear difference in adverse events: number of people experiencing adverse events (all… compared with control (low certainty).
1 finding from 1 review
Quality of life: SGRQ total or CCQ · COPD
1 finding from 1 review
Hospital admissions · COPD
It is very uncertain whether single component intervention changes hospital service utilisation: number of people admitted to hospital… compared with control (very low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · COPD
It is very uncertain whether single component intervention changes exacerbations: number of people experiencing exacerbations compared with control (very low certainty).
1 finding from 1 review
Adverse events: number of people experiencing adverse events (all cause or COPD‐related), serious adverse events, mortality · COPD
It is very uncertain whether single component intervention changes adverse events: number of people experiencing adverse events (all… compared with control (very low certainty).
1 finding from 1 review
Adherence to pharmacotherapy: number of people achieving adherence to medication · COPD
Multi‐component intervention may leads to higher adherence to pharmacotherapy: number of people achieving adherence… compared with control (low certainty).
1 finding from 1 review
Quality of life: SGRQ total, SF CRDQ total, CAT total · COPD
1 finding from 1 review
Hospital admissions · COPD
Multi‐component intervention may leads to lower hospital service utilisation: number of people admitted to hospital… compared with control (low certainty).
1 finding from 1 review